This is a news story, published by Guardian, that relates primarily to Richard Hulse news.
For more Richard Hulse news, you can click here:
more Richard Hulse newsFor more disease research news, you can click here:
more disease research newsFor more news from Guardian, you can click here:
more news from GuardianOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
chronic pain. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest childhood cancer survivors news, ongoing pain news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
nociceptor cellsGuardian
•
65% Informative
Eight out of 10 children survive their cancer for 10 years or more but more than half report delayed and ongoing pain in adulthood.
Dr Richard Hulse , a sensory neurophysiologist at Nottingham Trent University’s school of science and technology, is researching the pathways through which chemotherapy causes patients to experience ongoing pain by damaging nerve cells.
VR Score
67
Informative language
67
Neutral language
55
Article tone
informal
Language
English
Language complexity
59
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links